These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9432805)

  • 1. [Clinical pharmacology and possible applications of hyaluronidase with reference to Hylase "Dessau"].
    Farr C; Menzel J; Seeberger J; Schweigle B
    Wien Med Wochenschr; 1997; 147(15):347-55. PubMed ID: 9432805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hyaluronidase in plastic surgery: A review.
    Sharma DSC; Lahiri MA
    J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1610-1614. PubMed ID: 34024740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Applications of Hyaluronidase.
    Weber GC; Buhren BA; Schrumpf H; Wohlrab J; Gerber PA
    Adv Exp Med Biol; 2019; 1148():255-277. PubMed ID: 31482503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection.
    Andre P; Fléchet ML
    J Cosmet Dermatol; 2008 Jun; 7(2):136-8. PubMed ID: 18482018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of hyaluronidase in the treatment of intravenous extravasation injuries.
    Raszka WV; Kueser TK; Smith FR; Bass JW
    J Perinatol; 1990 Jun; 10(2):146-9. PubMed ID: 2358898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Animal experimental studies on immunogenicity, humoral response and danger of anaphylaxis in parenteral administration of hyaluronidase].
    Storch H; Dellas T; Bellmann H
    Z Exp Chir; 1978; 11(2):128-33. PubMed ID: 654375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of hyaluronidase 75 IU as an adjuvant to mepivacaine for retrobulbar anesthesia in cataract surgery.
    Remy M; Pinter F; Nentwich MM; Kampik A; Schönfeld CL
    J Cataract Refract Surg; 2008 Nov; 34(11):1966-9. PubMed ID: 19006746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronidase Caveats in Treating Filler Complications.
    Landau M
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S347-53. PubMed ID: 26618463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snake venom hyaluronidase: a therapeutic target.
    Kemparaju K; Girish KS
    Cell Biochem Funct; 2006; 24(1):7-12. PubMed ID: 16245359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management.
    Dunn AL; Heavner JE; Racz G; Day M
    Expert Opin Biol Ther; 2010 Jan; 10(1):127-31. PubMed ID: 20420518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients.
    Hilton S; Schrumpf H; Buhren BA; Bölke E; Gerber PA
    Eur J Med Res; 2014 May; 19(1):30. PubMed ID: 24886711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use.
    Rzany B; Becker-Wegerich P; Bachmann F; Erdmann R; Wollina U
    J Cosmet Dermatol; 2009 Dec; 8(4):317-23. PubMed ID: 19958438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronidase: from clinical applications to molecular and cellular mechanisms.
    Buhren BA; Schrumpf H; Hoff NP; Bölke E; Hilton S; Gerber PA
    Eur J Med Res; 2016 Feb; 21():5. PubMed ID: 26873038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronidase in Dermatology: Uses Beyond Hyaluronic Acid Fillers.
    Searle T; Ali FR; Al-Niaimi F
    J Drugs Dermatol; 2020 Oct; 19(10):993-998. PubMed ID: 33026763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyaluronidase: Here we go again].
    Etesse B; Beaudroit L; Deleuze M; Nouvellon E; Ripart J
    Ann Fr Anesth Reanim; 2009; 28(7-8):658-65. PubMed ID: 19577408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview.
    Girish KS; Kemparaju K
    Life Sci; 2007 May; 80(21):1921-43. PubMed ID: 17408700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of hylase Dessau in experimentally produced paratenonitis in the rabbit].
    Rauchfuss E; Bellmann H; Scheuner G; Hutschenreiter J; Kretschmar KH
    Z Exp Chir; 1973; 6(3):215-9. PubMed ID: 4772911
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
    Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
    Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hyaluronidase for pharmacokinetic increase in bioavailability of intracutaneously applied substances.
    Wohlrab J; Wohlrab D; Wohlrab L; Wohlrab C; Wohlrab A
    Skin Pharmacol Physiol; 2014; 27(5):276-82. PubMed ID: 24944044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
    Hirsch RJ; Brody HJ; Carruthers JD
    J Cosmet Laser Ther; 2007 Sep; 9(3):182-5. PubMed ID: 17763028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.